[THERAPEUTIC POSSIBILITIES IN TINNITUS].
D000086:Acetazolamide; D001808:Blood Vessels; D002118:Calcium; D005947:Glucose; D006311:Hearing Disorders; D006801:Humans; D007267:Injections; D007455:Iodine; D009411:Nerve Endings; D009525:Niacin; D009539:Nicotinic Acids; D004364:Pharmaceutical Preparations; D010827:Physiology; D011343:Procaine; D013805:Theobromine; D013806:Theophylline; D014012:Tinnitus; D014116:Toxicology
D009539:Nicotinic Acids; D004364:Pharmaceutical Preparations; D009525:Niacin; D011343:Procaine; D007455:Iodine; D013806:Theophylline; D005947:Glucose; D000086:Acetazolamide; D013805:Theobromine; D002118:Calcium
ACETAZOLAMIDE; BLOOD VESSELS; CALCIUM; DRUGS; GLUCOSE; HEARING DISORDERS; INJECTIONS; IODINE; NERVE ENDINGS; NICOTINIC ACID; PHYSIOLOGY; PROCAINE; THEOBROMINE; THEOPHYLLINE; TINNITUS; TOXICOLOGIC REPORT
THERAPEUTISCHE MOEGLICHKEITEN BEI OHRENSAUSEN.